| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.11e-06 | 9 | 197 | 4 | GO:0015379 | |
| GeneOntologyMolecularFunction | calcium ion binding | FKBP9 SVEP1 RYR1 RYR2 FAT1 FAT2 OTOF CCDC47 TCHHL1 PLS1 GPD2 PCDHGB7 PCDH11Y LALBA PCDHA10 HMCN1 TLL2 ANKEF1 SLIT1 ANXA10 UNC13C CDH18 | 5.14e-06 | 749 | 197 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 7.02e-05 | 23 | 197 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.16e-04 | 26 | 197 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 1.35e-04 | 27 | 197 | 4 | GO:0017134 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 1.95e-04 | 12 | 197 | 3 | GO:0008519 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | IQGAP2 MCF2L2 SIRPB1 RTKN ASAP2 VAV1 RANBP10 TBC1D15 ARHGEF12 ARHGAP35 ARHGEF10L ARHGEF33 RIMS1 RPGR | 5.31e-04 | 507 | 197 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | IQGAP2 MCF2L2 SIRPB1 RTKN ASAP2 VAV1 RANBP10 TBC1D15 ARHGEF12 ARHGAP35 ARHGEF10L ARHGEF33 RIMS1 RPGR | 5.31e-04 | 507 | 197 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 5.74e-04 | 4 | 197 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 5.81e-04 | 17 | 197 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 5.81e-04 | 17 | 197 | 3 | GO:0019198 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 3.25e-06 | 4 | 194 | 3 | GO:0140157 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT1 FAT2 PTPRG CNTN2 SDK2 PCDHGB7 PCDH11Y PCDHA10 HMCN1 CDH18 | 1.15e-05 | 187 | 194 | 10 | GO:0007156 |
| GeneOntologyCellularComponent | axon initial segment | 1.57e-04 | 29 | 199 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | main axon | 2.08e-04 | 89 | 199 | 6 | GO:0044304 | |
| Domain | SLC12A_fam | 3.94e-07 | 7 | 195 | 4 | IPR004842 | |
| Domain | SLC12_C | 7.81e-07 | 8 | 195 | 4 | IPR018491 | |
| Domain | SLC12 | 7.81e-07 | 8 | 195 | 4 | PF03522 | |
| Domain | KCL_cotranspt | 4.45e-06 | 4 | 195 | 3 | IPR000076 | |
| Domain | LAM_G_DOMAIN | 4.47e-05 | 38 | 195 | 5 | PS50025 | |
| Domain | Ig-like_fold | CD244 CEACAM4 GBE1 SIRPB1 HEPACAM2 IGSF10 NEO1 PTPRB PTPRG PTPRZ1 USH2A LILRA5 CNTN2 CDON SDK2 PKHD1L1 MILR1 HMCN1 BTN2A3P TNXB | 5.20e-05 | 706 | 195 | 20 | IPR013783 |
| Domain | fn3 | 5.24e-05 | 162 | 195 | 9 | PF00041 | |
| Domain | EGF | 5.37e-05 | 126 | 195 | 8 | PF00008 | |
| Domain | Laminin_G_2 | 5.76e-05 | 40 | 195 | 5 | PF02210 | |
| Domain | - | CD244 CEACAM4 GBE1 SIRPB1 HEPACAM2 IGSF10 NEO1 PTPRB PTPRG PTPRZ1 USH2A LILRA5 CNTN2 CDON SDK2 PKHD1L1 MILR1 HMCN1 TNXB | 6.93e-05 | 663 | 195 | 19 | 2.60.40.10 |
| Domain | AA-permease/SLC12A_dom | 7.27e-05 | 22 | 195 | 4 | IPR004841 | |
| Domain | AA_permease | 7.27e-05 | 22 | 195 | 4 | PF00324 | |
| Domain | LamG | 9.20e-05 | 44 | 195 | 5 | SM00282 | |
| Domain | KCC1 | 1.08e-04 | 2 | 195 | 2 | IPR000622 | |
| Domain | FN3 | 1.45e-04 | 185 | 195 | 9 | SM00060 | |
| Domain | FN3 | 2.50e-04 | 199 | 195 | 9 | PS50853 | |
| Domain | EGF-like_dom | 2.98e-04 | 249 | 195 | 10 | IPR000742 | |
| Domain | Ryanodine_rcpt | 3.23e-04 | 3 | 195 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 3.23e-04 | 3 | 195 | 2 | IPR009460 | |
| Domain | RyR | 3.23e-04 | 3 | 195 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 3.23e-04 | 3 | 195 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.23e-04 | 3 | 195 | 2 | IPR013333 | |
| Domain | Laminin_G | 3.45e-04 | 58 | 195 | 5 | IPR001791 | |
| Domain | FN3_dom | 3.59e-04 | 209 | 195 | 9 | IPR003961 | |
| Domain | EGF_1 | 3.60e-04 | 255 | 195 | 10 | PS00022 | |
| Domain | - | 4.82e-04 | 95 | 195 | 6 | 2.60.120.200 | |
| Domain | ConA-like_dom | 5.05e-04 | 219 | 195 | 9 | IPR013320 | |
| Domain | PTPc | 5.23e-04 | 36 | 195 | 4 | SM00194 | |
| Domain | VWF_A | 6.01e-04 | 99 | 195 | 6 | IPR002035 | |
| Domain | Carb_anhydrase | 6.84e-04 | 17 | 195 | 3 | PF00194 | |
| Domain | Carb_anhydrase | 6.84e-04 | 17 | 195 | 3 | SM01057 | |
| Domain | - | 6.84e-04 | 17 | 195 | 3 | 3.10.200.10 | |
| Domain | ALPHA_CA_2 | 6.84e-04 | 17 | 195 | 3 | PS51144 | |
| Domain | Carbonic_anhydrase_a | 6.84e-04 | 17 | 195 | 3 | IPR001148 | |
| Domain | TYR_PHOSPHATASE_PTP | 7.12e-04 | 39 | 195 | 4 | PS50055 | |
| Domain | RhoGEF | 7.21e-04 | 68 | 195 | 5 | SM00325 | |
| Domain | RhoGEF | 8.23e-04 | 70 | 195 | 5 | PF00621 | |
| Domain | DH_2 | 8.23e-04 | 70 | 195 | 5 | PS50010 | |
| Domain | EGF | 8.35e-04 | 235 | 195 | 9 | SM00181 | |
| Domain | EGF_3 | 8.35e-04 | 235 | 195 | 9 | PS50026 | |
| Domain | PTPase_domain | 8.63e-04 | 41 | 195 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 8.63e-04 | 41 | 195 | 4 | PF00102 | |
| Domain | - | 8.78e-04 | 71 | 195 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 8.78e-04 | 71 | 195 | 5 | IPR000219 | |
| Domain | Cadherin_CS | 9.97e-04 | 109 | 195 | 6 | IPR020894 | |
| Domain | - | 1.06e-03 | 74 | 195 | 5 | 3.40.50.410 | |
| Domain | FerI | 1.06e-03 | 5 | 195 | 2 | SM01202 | |
| Domain | FerB | 1.06e-03 | 5 | 195 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 1.06e-03 | 5 | 195 | 2 | IPR012561 | |
| Domain | Ferlin_C | 1.06e-03 | 5 | 195 | 2 | PF16165 | |
| Domain | Ferlin_C | 1.06e-03 | 5 | 195 | 2 | IPR032362 | |
| Domain | FerIin_dom | 1.06e-03 | 5 | 195 | 2 | IPR012968 | |
| Domain | FerI | 1.06e-03 | 5 | 195 | 2 | PF08151 | |
| Domain | FerB | 1.06e-03 | 5 | 195 | 2 | PF08150 | |
| Domain | SAPAP | 1.06e-03 | 5 | 195 | 2 | IPR005026 | |
| Domain | GKAP | 1.06e-03 | 5 | 195 | 2 | PF03359 | |
| Domain | CADHERIN_1 | 1.20e-03 | 113 | 195 | 6 | PS00232 | |
| Domain | Cadherin | 1.20e-03 | 113 | 195 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.26e-03 | 114 | 195 | 6 | PS50268 | |
| Domain | - | 1.26e-03 | 114 | 195 | 6 | 2.60.40.60 | |
| Domain | CA | 1.32e-03 | 115 | 195 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.38e-03 | 116 | 195 | 6 | IPR015919 | |
| Domain | Cadherin | 1.50e-03 | 118 | 195 | 6 | IPR002126 | |
| Domain | RIH_assoc-dom | 1.58e-03 | 6 | 195 | 2 | IPR013662 | |
| Domain | Nuc_rcpt_coact | 1.58e-03 | 6 | 195 | 2 | IPR009110 | |
| Domain | Ins145_P3_rec | 1.58e-03 | 6 | 195 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.58e-03 | 6 | 195 | 2 | PF08454 | |
| Domain | RIH_dom | 1.58e-03 | 6 | 195 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.58e-03 | 6 | 195 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.58e-03 | 6 | 195 | 2 | IPR015925 | |
| Domain | - | 1.58e-03 | 6 | 195 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.58e-03 | 6 | 195 | 2 | PF01365 | |
| Domain | IG | CD244 CEACAM4 SIRPB1 HEPACAM2 IGSF10 NEO1 LILRA5 CNTN2 CDON SDK2 MILR1 HMCN1 | 1.62e-03 | 421 | 195 | 12 | SM00409 |
| Domain | Ig_sub | CD244 CEACAM4 SIRPB1 HEPACAM2 IGSF10 NEO1 LILRA5 CNTN2 CDON SDK2 MILR1 HMCN1 | 1.62e-03 | 421 | 195 | 12 | IPR003599 |
| Domain | VWFA | 1.68e-03 | 82 | 195 | 5 | PS50234 | |
| Domain | C2_dom | 1.70e-03 | 164 | 195 | 7 | IPR000008 | |
| Domain | EGF-like_CS | 1.73e-03 | 261 | 195 | 9 | IPR013032 | |
| Domain | EGF_CA | 1.78e-03 | 122 | 195 | 6 | SM00179 | |
| Domain | VWA | 1.87e-03 | 84 | 195 | 5 | SM00327 | |
| Domain | EGF_2 | 1.92e-03 | 265 | 195 | 9 | PS01186 | |
| Domain | EGF-like_Ca-bd_dom | 1.93e-03 | 124 | 195 | 6 | IPR001881 | |
| Domain | WW_DOMAIN_1 | 1.96e-03 | 51 | 195 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 1.96e-03 | 51 | 195 | 4 | PS50020 | |
| Domain | WW_dom | 2.11e-03 | 52 | 195 | 4 | IPR001202 | |
| Domain | Ig-like_dom | CD244 CEACAM4 SIRPB1 HEPACAM2 IGSF10 NEO1 LILRA5 CNTN2 CDON SDK2 MILR1 HMCN1 BTN2A3P | 2.48e-03 | 503 | 195 | 13 | IPR007110 |
| Domain | C2 | 2.55e-03 | 131 | 195 | 6 | PF00168 | |
| Domain | VWA | 2.77e-03 | 56 | 195 | 4 | PF00092 | |
| Domain | IGc2 | 3.34e-03 | 235 | 195 | 8 | SM00408 | |
| Domain | Ig_sub2 | 3.34e-03 | 235 | 195 | 8 | IPR003598 | |
| Domain | PTPc_motif | 3.35e-03 | 59 | 195 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.35e-03 | 59 | 195 | 4 | IPR003595 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 3.88e-07 | 7 | 147 | 4 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 3.88e-07 | 7 | 147 | 4 | MM15081 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 MAP2 INPP5A PPP1R12A MAPK8IP3 CEP170 TMCO4 ZNF462 ASAP2 PTPN13 PTPRB PTPRG GPR158 BOD1L1 ATP11A SLC12A6 PCDH11Y KAT6A FRMPD1 HIPK2 ARHGAP35 AOPEP RBM5 ZFHX3 RIMS1 PBX3 ZMAT1 ZMYM4 | 4.66e-08 | 1489 | 202 | 28 | 28611215 |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 7.59e-08 | 8 | 202 | 4 | 21613606 | |
| Pubmed | 7.59e-08 | 8 | 202 | 4 | 11395011 | ||
| Pubmed | IQGAP2 PPP1R12A PFKP RYR2 FER1L6 KRT73 ACSL4 CCDC47 TCHHL1 GPC4 BOD1L1 ATP11A KIAA2012 TASOR PLS1 HSPA9 SLC17A6 SLC12A6 KIF13B COPA PCDHGB7 SF3B3 SLC12A4 RBM5 RIMS1 NGLY1 USPL1 | 9.06e-08 | 1442 | 202 | 27 | 35575683 | |
| Pubmed | 1.36e-07 | 9 | 202 | 4 | 19323993 | ||
| Pubmed | IQGAP2 SEC24A RYR2 FAT1 NEO1 PTPN13 UBR5 TASOR HSPA9 CDON CEP162 SPECC1L AGPS PKHD1L1 LIPE RBM5 ZFHX3 RPGR ZMAT1 | 1.65e-07 | 777 | 202 | 19 | 35844135 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 11551954 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 15262997 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 1.93e-07 | 3 | 202 | 3 | 21733850 | |
| Pubmed | DLGAP2 IQGAP2 MAP2 PPP1R12A FKBP9 PFKP MAPK8IP3 CEP170 PTPRZ1 PLEKHA7 HSPA9 CNTN2 GPD2 SLC12A6 COPA RTN4 DLGAP4 ARHGEF12 SPECC1L ARHGAP35 ELP3 SF3B3 LRRCC1 OTUD4 RIMS1 LGI1 | 2.86e-07 | 1431 | 202 | 26 | 37142655 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 12637262 | ||
| Pubmed | MAGI1 SEC24A CEP170 PTPN13 FBXO5 NSFL1C CCDC47 BOD1L1 EIF2AK3 HSPA9 GPD2 TBC1D15 COPA COBLL1 RTN4 ARHGEF12 SF3B3 | 9.73e-07 | 708 | 202 | 17 | 39231216 | |
| Pubmed | MAGI1 DLGAP2 IQGAP2 PPP1R12A SIRPB1 MAPK8IP3 CEP170 ZNF462 UBR5 GPR158 HSPA9 KIF13B RANBP10 DLGAP4 ARHGEF12 SPECC1L OTUD4 RIMS1 LGI1 PROX1 | 1.00e-06 | 963 | 202 | 20 | 28671696 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAGI1 IQGAP2 DCBLD1 FAT1 NEO1 PTPRG GPR158 ATP11A PLEKHA7 KIF13B RAB11FIP1 FRMD4A OPTN SLC12A4 SLC12A7 | 1.39e-06 | 569 | 202 | 15 | 30639242 |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 2169617 | ||
| Pubmed | 2.02e-06 | 64 | 202 | 6 | 22261194 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 MAGI1 MAP2 SEC24A PPP1R12A PFKP RTKN CEP170 FSIP2 PTPN13 BOD1L1 PLEKHA7 KIF13B CEP162 COBLL1 RAB11FIP1 OPTN DYRK1B | 3.26e-06 | 861 | 202 | 18 | 36931259 |
| Pubmed | Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. | 3.81e-06 | 6 | 202 | 3 | 2170109 | |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 19009018 | ||
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 11283609 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 7.44e-06 | 22 | 202 | 4 | 18391953 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 7.71e-06 | 171 | 202 | 8 | 20201926 | |
| Pubmed | 1.01e-05 | 234 | 202 | 9 | 36243803 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 1.06e-05 | 8 | 202 | 3 | 24393035 | |
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 12386165 | ||
| Pubmed | 1.16e-05 | 130 | 202 | 7 | 12421765 | ||
| Pubmed | 1.41e-05 | 134 | 202 | 7 | 19030180 | ||
| Pubmed | Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. | 1.58e-05 | 9 | 202 | 3 | 14532115 | |
| Pubmed | RNMT IQGAP2 PPP1R12A CEACAM4 PTPN13 GPC4 BOD1L1 ATP11A MMP1 PLEKHA7 TASOR KIF13B CEP162 FRMPD1 HIPK2 AOPEP OTUD4 ASXL2 ZMAT1 | 2.07e-05 | 1084 | 202 | 19 | 11544199 | |
| Pubmed | 2.13e-05 | 257 | 202 | 9 | 16335952 | ||
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 17192421 | ||
| Pubmed | PPP1R12A FKBP9 GBE1 PFKP PM20D2 CEP170 FAT1 UBR5 CCDC47 BOD1L1 ATP11A HSPA9 TBC1D15 COPA EEF1E1 RTN4 AGPS RAB11FIP1 TMEM106B OPTN TSPAN6 | 2.43e-05 | 1297 | 202 | 21 | 33545068 | |
| Pubmed | MAGI1 PPP1R12A MCF2L2 PSMB5 CEP170 ASAP2 CCDC47 PLEKHA7 VAV1 COPA EEF1E1 ARHGEF12 API5 ARHGAP35 ARHGEF10L DYRK1B RBM5 | 2.82e-05 | 916 | 202 | 17 | 32203420 | |
| Pubmed | 3.02e-05 | 102 | 202 | 6 | 10231032 | ||
| Pubmed | VWA8 PPP1R12A SIRPB1 CEP170 FAT1 FBXO5 UBR5 SCN5A VAV1 WWC1 POLD1 KAT6A RAB11FIP1 DICER1 ARHGEF33 SF3B3 ZFHX3 PROX1 ALG13 | 3.08e-05 | 1116 | 202 | 19 | 31753913 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MAGI1 ZNF143 IQGAP2 PPP1R12A PFKP RTKN NME8 CEP170 ASAP2 PTPN13 PTPRG PLEKHA7 KIF13B RANBP10 VTN POLD1 COBLL1 RAB11FIP1 DICER1 SF3B3 RPGR | 3.17e-05 | 1321 | 202 | 21 | 27173435 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.17e-05 | 208 | 202 | 8 | 33230847 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 28248701 | ||
| Pubmed | Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies. | 3.36e-05 | 2 | 202 | 2 | 32911250 | |
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 3.36e-05 | 2 | 202 | 2 | 34031912 | |
| Pubmed | Genetic variants in autism-related CNTNAP2 impair axonal growth of cortical neurons. | 3.36e-05 | 2 | 202 | 2 | 29788201 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 23723061 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 17259277 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 3.36e-05 | 2 | 202 | 2 | 14722100 | |
| Pubmed | The juxtaparanodal proteins CNTNAP2 and TAG1 regulate diet-induced obesity. | 3.36e-05 | 2 | 202 | 2 | 22752552 | |
| Pubmed | SLC12A ion transporter mutations in sporadic and familial human congenital hydrocephalus. | 3.36e-05 | 2 | 202 | 2 | 31393094 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 3.36e-05 | 2 | 202 | 2 | 26009179 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 32899693 | ||
| Pubmed | A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk. | 3.36e-05 | 2 | 202 | 2 | 25990289 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 32799011 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 23400959 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 26217189 | ||
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 3.36e-05 | 2 | 202 | 2 | 31835175 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 3.36e-05 | 2 | 202 | 2 | 15033925 | |
| Pubmed | Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. | 3.36e-05 | 2 | 202 | 2 | 26289036 | |
| Pubmed | Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. | 3.36e-05 | 2 | 202 | 2 | 23407760 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 28543060 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 20219992 | ||
| Pubmed | Genetic analysis in post-mortem samples with micro-ischemic alterations. | 3.36e-05 | 2 | 202 | 2 | 28086167 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 17510708 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 30542613 | ||
| Pubmed | Manganese-enhanced magnetic resonance imaging (MEMRI) of mouse brain development. | 3.36e-05 | 2 | 202 | 2 | 15761950 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 15280431 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 10347194 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 3.36e-05 | 2 | 202 | 2 | 11673493 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 11673462 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 25931204 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 3.36e-05 | 2 | 202 | 2 | 25370123 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 3.36e-05 | 2 | 202 | 2 | 18618700 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 27621318 | ||
| Pubmed | CEP170 ZNF462 FAT2 ASAP2 ADAMTS9 ATP11A TASOR KIF13B RANBP10 COBLL1 ARHGAP35 LRRCC1 | 3.51e-05 | 493 | 202 | 12 | 15368895 | |
| Pubmed | DLGAP2 MAP2 VWA8 PLPPR3 PALMD RYR2 MAPK8IP3 CEP170 NEO1 NSFL1C GPR158 HSPA9 EEF1E1 RTN4 DLGAP4 ARHGAP35 FRMD4A CNTNAP2 RIMS1 | 4.05e-05 | 1139 | 202 | 19 | 36417873 | |
| Pubmed | A shared vesicular carrier allows synaptic corelease of GABA and glycine. | 4.09e-05 | 12 | 202 | 3 | 16701208 | |
| Pubmed | 4.09e-05 | 12 | 202 | 3 | 15134635 | ||
| Pubmed | ACSL4 NEO1 PTPN13 CCDC47 EIF2AK3 GPD2 SLC12A6 TBC1D15 RTN4 TMEM106B SLC12A4 SLC12A7 | 4.34e-05 | 504 | 202 | 12 | 34432599 | |
| Pubmed | 4.64e-05 | 284 | 202 | 9 | 29459677 | ||
| Pubmed | 5.29e-05 | 13 | 202 | 3 | 12376551 | ||
| Pubmed | 5.29e-05 | 13 | 202 | 3 | 11306624 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 6.03e-05 | 168 | 202 | 7 | 30631154 | |
| Pubmed | 9.01e-05 | 124 | 202 | 6 | 35516420 | ||
| Pubmed | Cells of a common developmental origin regulate REM/non-REM sleep and wakefulness in mice. | 1.00e-04 | 3 | 202 | 2 | 26494173 | |
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 18403125 | ||
| Pubmed | RGMb controls aggregation and migration of Neogenin-positive cells in vitro and in vivo. | 1.00e-04 | 3 | 202 | 2 | 19944164 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 1.00e-04 | 3 | 202 | 2 | 15744052 | |
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 7876312 | ||
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 24123915 | ||
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 38952869 | ||
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 7903253 | ||
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 23278119 | ||
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 28533267 | ||
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 22948152 | ||
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 16513268 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.00e-04 | 3 | 202 | 2 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.00e-04 | 3 | 202 | 2 | 7621815 | |
| Pubmed | Molecular evidence for a role for K(+)-Cl(-) cotransporters in the kidney. | 1.00e-04 | 3 | 202 | 2 | 24089410 | |
| Pubmed | Protein tyrosine phosphatase zeta/RPTPbeta interacts with PSD-95/SAP90 family. | 1.00e-04 | 3 | 202 | 2 | 10521598 | |
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 20962216 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.00e-04 | 3 | 202 | 2 | 10473538 | |
| Pubmed | Ammonium transport and pH regulation by K(+)-Cl(-) cotransporters. | 1.00e-04 | 3 | 202 | 2 | 12657561 | |
| Pubmed | 1.00e-04 | 3 | 202 | 2 | 32713021 | ||
| Interaction | INPP5E interactions | 3.19e-06 | 65 | 196 | 7 | int:INPP5E | |
| Cytoband | 12q15-q21 | 5.76e-05 | 3 | 202 | 2 | 12q15-q21 | |
| GeneFamily | Fibronectin type III domain containing | 2.35e-06 | 160 | 130 | 9 | 555 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.12e-04 | 66 | 130 | 5 | 722 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.53e-04 | 3 | 130 | 2 | 287 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.65e-04 | 161 | 130 | 7 | 593 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.29e-04 | 17 | 130 | 3 | 486 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.39e-04 | 21 | 130 | 3 | 813 | |
| GeneFamily | Immunoglobulin like domain containing | 4.95e-04 | 193 | 130 | 7 | 594 | |
| GeneFamily | Ferlin family | 7.55e-04 | 6 | 130 | 2 | 828 | |
| GeneFamily | PDZ domain containing | 8.10e-04 | 152 | 130 | 6 | 1220 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 2.70e-03 | 11 | 130 | 2 | 1168 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SEC24A PPP1R12A GBE1 MBOAT2 CEP170 ACSL4 FAT1 ASAP2 PTPN13 UBR5 TASOR WWC1 KAT6A SPECC1L ARHGAP35 DICER1 KIF20B OTUD4 NCOA1 ZFHX3 RPGR PBX3 ZMYM4 | 1.67e-07 | 856 | 199 | 23 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MAP2 PFKP CHRNA4 PXK RYR2 ZNF462 FSIP2 ACSL4 FAT2 GPR158 BOD1L1 C2CD6 CA1 CDON SLC17A6 RTN4 ARHGEF12 ARHGAP35 DICER1 OPTN CNTNAP2 OTUD4 ZFHX3 RIMS1 PBX3 ZMAT1 | 3.31e-07 | 1106 | 199 | 26 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SEC24A PPP1R12A GBE1 CEP170 FAT1 ASAP2 UBR5 TASOR WWC1 KAT6A SPECC1L KIF20B NCOA1 RPGR PBX3 ZMYM4 | 6.13e-07 | 466 | 199 | 16 | M13522 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.73e-06 | 196 | 199 | 10 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | SVEP1 IGSF10 VWA3B USH2A IMPG2 FRAS1 VTN HMCN1 SLIT1 TNXB LGI1 | 8.94e-06 | 275 | 199 | 11 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.64e-05 | 191 | 199 | 9 | MM17059 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 2.27e-05 | 199 | 199 | 9 | M7325 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN | 2.27e-05 | 199 | 199 | 9 | M6172 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 3.60e-05 | 25 | 199 | 4 | M47986 | |
| Coexpression | NABA_CORE_MATRISOME | 4.41e-05 | 270 | 199 | 10 | MM17057 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | TSPAN18 IQGAP2 MAP2 GBE1 PFKP ZNF462 ACSL4 FAT1 ASAP2 PTPRZ1 CDON SDK2 VTN PCDHGB7 KAT6A PCDHA10 ARHGAP35 RAB11FIP1 ARHGEF10L DYRK1B TSPAN6 RBM5 PBX3 LGI1 | 1.14e-05 | 967 | 197 | 24 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | DLGAP2 NDST4 RYR1 RYR2 GPR158 USH2A DPP10 XIRP2 CNTNAP2 RIMS1 CDH18 | 1.65e-10 | 159 | 200 | 11 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-08 | 184 | 200 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-08 | 184 | 200 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-08 | 184 | 200 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.41e-08 | 139 | 200 | 9 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | PRSS8 GPR158 PTPRZ1 ATP11A PLS1 WWC1 FRAS1 COBLL1 LRRC36 HDC | 1.60e-08 | 190 | 200 | 10 | 625c08a0e5227efc46daa512fd579c3938ff76c7 |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-08 | 145 | 200 | 9 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | MAGI1 TSPAN18 FKBP9 PALMD TNMD PTPRB PTPRG ADAMTS9 HMCN1 TSPAN6 | 2.04e-08 | 195 | 200 | 10 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-08 | 196 | 200 | 10 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-08 | 156 | 200 | 9 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-08 | 160 | 200 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-08 | 160 | 200 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-07 | 175 | 200 | 9 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-07 | 176 | 200 | 9 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-07 | 176 | 200 | 9 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-07 | 176 | 200 | 9 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 1.81e-07 | 187 | 200 | 9 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-07 | 190 | 200 | 9 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | MAGI1 RYR2 MAPK8IP3 FAT1 ATP11A EIF2AK3 ARHGEF12 XIRP2 AOPEP | 2.08e-07 | 190 | 200 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.08e-07 | 190 | 200 | 9 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.27e-07 | 192 | 200 | 9 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.53e-07 | 141 | 200 | 8 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAGI1 FAT1 PTPN13 PLEKHA7 WWC1 FRAS1 COBLL1 ARHGEF10L UNC13C | 2.70e-07 | 196 | 200 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.20e-07 | 200 | 200 | 9 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.20e-07 | 200 | 200 | 9 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.20e-07 | 200 | 200 | 9 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.20e-07 | 200 | 200 | 9 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.67e-07 | 148 | 200 | 8 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.29e-07 | 162 | 200 | 8 | f12c08d0d4406f9560ecfc3bc2ff38c3bc58f184 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-07 | 166 | 200 | 8 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-07 | 166 | 200 | 8 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-07 | 166 | 200 | 8 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.36e-06 | 176 | 200 | 8 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.36e-06 | 176 | 200 | 8 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-06 | 176 | 200 | 8 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-06 | 178 | 200 | 8 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 180 | 200 | 8 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-06 | 180 | 200 | 8 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.68e-06 | 181 | 200 | 8 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-06 | 182 | 200 | 8 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-06 | 183 | 200 | 8 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-06 | 128 | 200 | 7 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.90e-06 | 184 | 200 | 8 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.98e-06 | 185 | 200 | 8 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.98e-06 | 185 | 200 | 8 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.06e-06 | 186 | 200 | 8 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 2.14e-06 | 187 | 200 | 8 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.14e-06 | 187 | 200 | 8 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 187 | 200 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.32e-06 | 189 | 200 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-06 | 189 | 200 | 8 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.41e-06 | 190 | 200 | 8 | b7ce76931edc6734b80ddbb2fca23b098a8c1352 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.51e-06 | 191 | 200 | 8 | 989bf108c7f2c78dd7f14481570f1819673a5469 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.51e-06 | 191 | 200 | 8 | bc2f3c4e71e3a55fe76ea03f45746329a8fc81da | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.51e-06 | 191 | 200 | 8 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.51e-06 | 191 | 200 | 8 | 3e7fbe4af2c23b3b964becde843d2f088ad41c23 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.60e-06 | 192 | 200 | 8 | 2e8611d65090e39f1a6e74c972288e7b68376d15 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.60e-06 | 192 | 200 | 8 | d9ff2293358c8b031ba212021012e058014ff472 | |
| ToppCell | Severe_COVID-19-Myeloid-pDC|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.60e-06 | 192 | 200 | 8 | f79424c643a375dfe4579eff7ac1ba191e28a283 | |
| ToppCell | Influenza_Severe-RBC|Influenza_Severe / Disease group and Cell class | 2.60e-06 | 192 | 200 | 8 | f19b6da3fd98da1a76d2570137a8f73a3850ebcb | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.60e-06 | 192 | 200 | 8 | 43569726df281eebe57499e0993b9fd9d36118c2 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 2.71e-06 | 193 | 200 | 8 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.71e-06 | 193 | 200 | 8 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 193 | 200 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.71e-06 | 193 | 200 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | severe_influenza-RBC|severe_influenza / disease group, cell group and cell class (v2) | 2.71e-06 | 193 | 200 | 8 | ffb0b3c2cce13b6891157f0fede2600f3938670e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 194 | 200 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 194 | 200 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 194 | 200 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-06 | 194 | 200 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 194 | 200 | 8 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 194 | 200 | 8 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-06 | 194 | 200 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.03e-06 | 196 | 200 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.03e-06 | 196 | 200 | 8 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 196 | 200 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-06 | 198 | 200 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-06 | 198 | 200 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.27e-06 | 198 | 200 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-06 | 198 | 200 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.40e-06 | 199 | 200 | 8 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-06 | 199 | 200 | 8 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 199 | 200 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.52e-06 | 200 | 200 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.52e-06 | 200 | 200 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class | 3.52e-06 | 200 | 200 | 8 | 308f74e7e13ecc6d133c219c42cc8895a96644c8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-06 | 200 | 200 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.31e-06 | 150 | 200 | 7 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.79e-06 | 152 | 200 | 7 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.87e-06 | 156 | 200 | 7 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-06 | 160 | 200 | 7 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-06 | 160 | 200 | 7 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-06 | 160 | 200 | 7 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.79e-06 | 162 | 200 | 7 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.79e-06 | 162 | 200 | 7 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-06 | 165 | 200 | 7 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-05 | 166 | 200 | 7 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 1.11e-05 | 168 | 200 | 7 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| Disease | Age related macular degeneration | 4.52e-05 | 30 | 196 | 4 | C0242383 | |
| Disease | epilepsy (implicated_via_orthology) | 1.14e-04 | 163 | 196 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 1.31e-04 | 3 | 196 | 2 | C0349788 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.31e-04 | 3 | 196 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.31e-04 | 3 | 196 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | stroke, major depressive disorder | 2.59e-04 | 19 | 196 | 3 | EFO_0000712, MONDO_0002009 | |
| Disease | Macrostomia | 2.61e-04 | 4 | 196 | 2 | C0024433 | |
| Disease | Colorectal Carcinoma | TET2 CYP1A2 MAP2 MCF2L2 KRT73 ACSL4 FAT1 C2CD6 MMP1 POLD1 RTN4 ARHGEF10L ZMYM4 HDC | 2.71e-04 | 702 | 196 | 14 | C0009402 |
| Disease | red blood cell density measurement | TET2 FKBP9 PXK ZNF462 UBR5 ATP11A TASOR PLS1 LILRA5 CNTN2 COBLL1 KIF20B FRMD4A POLI OTUD4 PROX1 | 2.81e-04 | 880 | 196 | 16 | EFO_0007978 |
| Disease | Schizophrenia | MAGI1 CYP1A2 DLGAP2 TSPAN18 INPP5A SIRPB1 CHRNA4 PTPRZ1 HSPA9 SLC17A6 RTN4 CASP4 DICER1 CNTNAP2 EN1 TNXB | 2.92e-04 | 883 | 196 | 16 | C0036341 |
| Disease | unipolar depression, neuroticism measurement | 5.27e-04 | 24 | 196 | 3 | EFO_0003761, EFO_0007660 | |
| Disease | Deafness | 5.96e-04 | 25 | 196 | 3 | C0011053 | |
| Disease | response to interferon | 5.96e-04 | 25 | 196 | 3 | EFO_0007859 | |
| Disease | melanoma-associated antigen 10 measurement | 6.47e-04 | 6 | 196 | 2 | EFO_0801793 | |
| Disease | atrial fibrillation | 8.89e-04 | 371 | 196 | 9 | EFO_0000275 | |
| Disease | testosterone measurement | TET2 MAGI1 TSPAN18 SPEM3 PTPRG C2 USH2A EFL1 COBLL1 DLGAP4 LIPE HMCN1 AOPEP ANXA10 CNTNAP2 NCOA1 ZFHX3 LRRC36 PROX1 | 8.93e-04 | 1275 | 196 | 19 | EFO_0004908 |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 9.02e-04 | 7 | 196 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Cone-Rod Dystrophy 2 | 9.29e-04 | 29 | 196 | 3 | C3489532 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 1.20e-03 | 8 | 196 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | attempted suicide | 1.26e-03 | 178 | 196 | 6 | EFO_0004321 | |
| Disease | blood nickel measurement | 1.26e-03 | 120 | 196 | 5 | EFO_0007583 | |
| Disease | platelet measurement | 1.28e-03 | 315 | 196 | 8 | EFO_0005036 | |
| Disease | FEV/FEC ratio | TET2 RNMT MAP2 DCBLD1 ASAP2 CNTN2 CDON MGAM FRAS1 EEF1E1 FTMT FRMD4A HMCN1 CNTNAP2 OTUD4 ZFHX3 TNXB HDC | 1.46e-03 | 1228 | 196 | 18 | EFO_0004713 |
| Disease | interleukin-36 alpha measurement | 1.53e-03 | 9 | 196 | 2 | EFO_0021851 | |
| Disease | Long QT Syndrome | 2.32e-03 | 11 | 196 | 2 | C0023976 | |
| Disease | glomerulosclerosis (implicated_via_orthology) | 2.32e-03 | 11 | 196 | 2 | DOID:0050851 (implicated_via_orthology) | |
| Disease | Tachycardia, Ventricular | 2.32e-03 | 11 | 196 | 2 | C0042514 | |
| Disease | glycerol-3-phosphate dehydrogenase 1-like protein measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0801640 | |
| Disease | Autism Spectrum Disorders | 2.51e-03 | 85 | 196 | 4 | C1510586 | |
| Disease | emphysema imaging measurement | 2.98e-03 | 146 | 196 | 5 | EFO_0007626 | |
| Disease | Disorder of eye | 3.02e-03 | 212 | 196 | 6 | C0015397 | |
| Disease | sexual dimorphism measurement | TET2 ZNF462 PTPRG TASOR LILRA5 RANBP10 MGAM COBLL1 RTN4 DLGAP4 SLC12A3 AOPEP SLIT1 OTUD4 ZFHX3 ASXL2 | 3.04e-03 | 1106 | 196 | 16 | EFO_0021796 |
| Disease | Takayasu arteritis | 3.16e-03 | 148 | 196 | 5 | EFO_1001857 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 3.31e-03 | 216 | 196 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | Squamous cell carcinoma of esophagus | 3.75e-03 | 95 | 196 | 4 | C0279626 | |
| Disease | vital capacity | TET2 MAP2 SVEP1 RYR2 KIAA2012 EIF2AK3 CEP162 FRMPD1 PCDHA10 AGPS LCT HMCN1 OTUD4 NCOA1 ZFHX3 EN1 TNXB | 3.78e-03 | 1236 | 196 | 17 | EFO_0004312 |
| Disease | Bagassosis | 3.79e-03 | 14 | 196 | 2 | C0004681 | |
| Disease | Pneumoconiosis | 3.79e-03 | 14 | 196 | 2 | C0032273 | |
| Disease | cortical surface area measurement | TET2 MAGI1 IQGAP2 MAP2 INPP5A SVEP1 NEO1 ADAMTS9 PLEKHA7 PLS1 WWC1 CEP162 HIPK2 ARHGEF12 KIF20B AOPEP ZFHX3 TNXB | 3.87e-03 | 1345 | 196 | 18 | EFO_0010736 |
| Disease | familial atrial fibrillation | 3.95e-03 | 156 | 196 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.95e-03 | 156 | 196 | 5 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 3.95e-03 | 156 | 196 | 5 | C0235480 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.25e-03 | 49 | 196 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 4.25e-03 | 49 | 196 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | thrombosis (is_implicated_in) | 4.35e-03 | 15 | 196 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | 1,3,7-trimethylurate measurement | 4.35e-03 | 15 | 196 | 2 | EFO_0021172 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 4.35e-03 | 15 | 196 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | obsolete aging, cognition | 4.35e-03 | 15 | 196 | 2 | EFO_0003925, GO_0007568 | |
| Disease | Atrial Fibrillation | 4.40e-03 | 160 | 196 | 5 | C0004238 | |
| Disease | Adenoid Cystic Carcinoma | 4.51e-03 | 100 | 196 | 4 | C0010606 | |
| Disease | taste liking measurement | 4.59e-03 | 388 | 196 | 8 | EFO_0010155 | |
| Disease | coffee consumption, cups of coffee per day measurement | 4.95e-03 | 16 | 196 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | neutrophil collagenase measurement | 4.95e-03 | 16 | 196 | 2 | EFO_0008248 | |
| Disease | reading and spelling ability | 5.13e-03 | 166 | 196 | 5 | EFO_0005301 | |
| Disease | lung carcinoma | 5.14e-03 | 482 | 196 | 9 | EFO_0001071 | |
| Disease | response to TNF antagonist | 5.58e-03 | 54 | 196 | 3 | EFO_0004653 | |
| Disease | Hepatomegaly | 5.58e-03 | 54 | 196 | 3 | C0019209 | |
| Disease | SLAM family member 7 measurement | 5.59e-03 | 17 | 196 | 2 | EFO_0008287 | |
| Disease | Holoprosencephaly | 5.59e-03 | 17 | 196 | 2 | C0079541 | |
| Disease | Premature atrial contractions | 5.88e-03 | 55 | 196 | 3 | HP_0006699 | |
| Disease | Age-related macular degeneration | 6.26e-03 | 18 | 196 | 2 | cv:C0242383 | |
| Disease | disease free survival | 6.26e-03 | 18 | 196 | 2 | EFO_0000409 | |
| Disease | coronary artery disease | TET2 CYP1A2 SVEP1 MAPK8IP3 IGSF10 ASAP2 C2 PLEKHA7 DPP10 ASZ1 ARHGEF12 FTMT SPECC1L TMEM106B SF3B3 TNXB | 6.27e-03 | 1194 | 196 | 16 | EFO_0001645 |
| Disease | cardiac troponin I measurement | 6.55e-03 | 176 | 196 | 5 | EFO_0010071 | |
| Disease | age at menarche | TET2 DLGAP2 NDST4 ZNF462 PTPRG PLEKHA7 EFL1 HELQ SLIT1 UNC13C | 6.62e-03 | 594 | 196 | 10 | EFO_0004703 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGKETEVSSNQLHSY | 1121 | P23470 | |
| QESFASGKHYLEVDV | 346 | Q96KV6 | |
| KEAVVHGLNESEASY | 186 | O60488 | |
| KQHAVINYDASTDEH | 41 | Q5SW79 | |
| YNNADGDFAVTHLTK | 126 | P43681 | |
| DGGTYDKDNVLIQHS | 616 | Q9HCE6 | |
| NASYDSDQATGQLHV | 126 | O75871 | |
| RNNAVTGSEDAHTDY | 396 | Q9NP73 | |
| TGSEDAHTDYKSSNQ | 401 | Q9NP73 | |
| SNNLQEDIYSETSGH | 136 | Q9UJ72 | |
| TENKYDSVSGEANDS | 561 | Q9NZJ5 | |
| HEKYNSATEGNDIAL | 131 | P10323 | |
| QSSENLEEDAVYKTH | 281 | P49662 | |
| EENGSTSKTIVYHLD | 306 | Q96A70 | |
| KSSAISLHYATGNEE | 71 | Q7Z2Z2 | |
| YEKAQESRSVHVGDS | 166 | A8MVX0 | |
| AELYSIHNSGDKSDI | 591 | Q69YQ0 | |
| LEHGADVNNSTYEGK | 136 | Q9NU02 | |
| GEHQTQTYLQAASDV | 476 | Q9P1A6 | |
| DATEQVGQHKDAYQV | 16 | Q9BZZ5 | |
| HDNQEHASGISSSKY | 116 | Q8N6M6 | |
| HSDLKVGEYSNLEVN | 116 | Q9UPY3 | |
| DLVQGVYHENSTSKE | 221 | Q86YH6 | |
| TKSTDGQEPHSVVYD | 481 | Q53SF7 | |
| QDTYLDSQDHKSEVT | 586 | Q9Y2H0 | |
| SKEESTYQAASVLHN | 696 | Q8N608 | |
| SFGQVVKAYDHQTQE | 121 | Q9Y463 | |
| THQYHEGLSKATQDQ | 1051 | Q76L83 | |
| HGAEVNTQDENGYTA | 171 | Q8WWH4 | |
| VIQNSENIKAYHSGE | 1296 | Q9NZN5 | |
| NGAYKHEDLQTDESS | 476 | Q6VN20 | |
| ANYRESAEDTQKHDT | 166 | Q6ZP01 | |
| VSESHGQLSYQADLE | 801 | Q01804 | |
| HYQDFDKNSVRDITG | 271 | P05177 | |
| DKAQHVFSLDYTTGN | 286 | Q9Y5F8 | |
| VAYASDQAHSSVEKA | 186 | P19113 | |
| AHSQSSVVYEIKDGN | 1691 | Q14517 | |
| ANAEITYSIISGNEH | 3261 | Q14517 | |
| DDGQKSVYAVSSNHS | 211 | Q9NP74 | |
| GSSDNSIEHSDYRAK | 141 | P40426 | |
| SGKYENHSFSQERTV | 716 | P23467 | |
| DSGTASHLQDYAVEN | 251 | A6NI73 | |
| EKNALQYIHDGSSTR | 1666 | Q86XX4 | |
| VQYVHSSEAEKHSDA | 2271 | Q86XX4 | |
| SEVAQHLAATYGDKA | 491 | P43304 | |
| SGSNSEGDYQLVQHE | 176 | Q9H2X6 | |
| TENGEVYFIDHNTKT | 311 | Q96QZ7 | |
| YEGETAQIQSHISDT | 271 | Q86Y46 | |
| VNKAFGINTDSLYHE | 371 | Q9UPT6 | |
| QVELTGDNSLHSYAD | 591 | Q96IV0 | |
| SYHITQSGENGKEET | 206 | Q6ZWT7 | |
| QVGDYFIDHNTKTTQ | 66 | Q8IX03 | |
| FDYNATDHAGKSANE | 511 | O75487 | |
| QHISGSTKDVSEEAY | 376 | Q5T848 | |
| INSSGLAHVENEEQY | 61 | O43150 | |
| SSLENANYKDHENGT | 321 | P06681 | |
| VSDVQYNSHGATADI | 1901 | O43451 | |
| VYGNIDIHASDKSAV | 206 | Q8N0U4 | |
| SSGLVHINDKTSDYE | 596 | Q53TS8 | |
| DQNTYKETHGHTANA | 351 | Q5CZC0 | |
| ATSTGKLNQENEHIY | 191 | Q96A33 | |
| VNSVSDLHGYIDKSQ | 166 | Q86YR7 | |
| ISSEGTQHSYSEEEK | 111 | Q14651 | |
| VNAEVHYSLLKGNSE | 1586 | Q9NYQ8 | |
| LDENYKSQEHFTALG | 91 | Q14642 | |
| HGLSAEQVYNADETG | 176 | O75564 | |
| AISIVSGQQSHTYDD | 631 | Q1X8D7 | |
| ASYDVSDSGQLEHVQ | 766 | Q01813 | |
| GQSNFEEHIYGNETS | 116 | Q8N292 | |
| ATKVETEETHNYVGF | 661 | Q96Q89 | |
| GKAYESVNSNISHEE | 621 | Q0VF49 | |
| HTSGYDTQAIVENNE | 51 | P00709 | |
| EGQATLEVASDSYHK | 421 | P09848 | |
| EYSVSIIGFHKANEN | 156 | Q9H3R1 | |
| HNTGKTVEINLTNDY | 96 | P23471 | |
| AYVAGEKRQHSSQDV | 166 | Q9UNZ2 | |
| ETAENYLGHTAKNAV | 176 | P38646 | |
| GLYNHSTTTVQDKDE | 376 | Q05925 | |
| VNYEQPTKDGIDHSN | 731 | P52756 | |
| AQDEAKHSQELQYAT | 301 | Q7Z6M3 | |
| YQLTHNGKTCQDIDE | 5461 | Q96RW7 | |
| NVEHGDSSAYENVKF | 116 | Q8IV76 | |
| DSNTYEIHVDVTDKG | 311 | Q9Y5I2 | |
| YTLEHNDGSQSDTAV | 1406 | Q86UR5 | |
| EEFSEYIHAQVASGK | 511 | O95302 | |
| SVSHENKEQDSYSVE | 816 | Q92794 | |
| GFRTNEEIHSESYNK | 2721 | Q8NFC6 | |
| EEIHSESYNKGEISS | 2726 | Q8NFC6 | |
| RSLESDQEGHYSVKA | 851 | Q9P2Q2 | |
| KEYVTLVHGDSENFS | 1776 | Q9P2N4 | |
| YAESHDQALVGDKSL | 476 | Q04446 | |
| DYSSDDNLTGQAAHK | 206 | P52951 | |
| HDNGTLVIKEATAYD | 2486 | Q6WRI0 | |
| QKGSTYSRHNEFSEV | 351 | Q9UKT4 | |
| TNEHGSEHTVDGVKY | 101 | P00915 | |
| DESGVFIYTTSNHIK | 536 | P53621 | |
| KQQAHRVSAEEGYES | 506 | Q5SYB0 | |
| TQEHAGKYICEAANE | 491 | Q4KMG0 | |
| GKYICEAANEHGTTQ | 496 | Q4KMG0 | |
| SYGQSSSDVEALHQA | 281 | Q5TB80 | |
| VAENKHGTIYASAEL | 396 | Q02246 | |
| GSTELVEDSHYSQSQ | 11 | Q9HAW0 | |
| DALSGHTSNNIYEAV | 191 | Q9H9T3 | |
| SSTVAAHYNELQEVG | 146 | O43148 | |
| KSYTLNIEGANTHLD | 341 | Q13634 | |
| GTYHTNEAKGAESAE | 1291 | Q9UHC6 | |
| QNEEIVAHDGSATYL | 101 | Q9Y547 | |
| YHTNEAKGTEFAESA | 91 | P04921 | |
| TEYRKAQTFSGHEDA | 391 | A8MVW5 | |
| SKGFSVSERYAHQQE | 5751 | Q8NDH2 | |
| TELQTDKHTENQSGY | 166 | Q8TDG4 | |
| DKHTENQSGYEGVTI | 171 | Q8TDG4 | |
| HQSAEFTISYDNEKE | 511 | Q8N8Z6 | |
| RESHQIGDAYSNSDK | 121 | Q8TAL6 | |
| DELSAVTVSGHVYNN | 171 | Q9UNA4 | |
| YTNLTQGAKEHEEAE | 156 | Q9UHW9 | |
| NYTNLSQGVVEHEED | 91 | Q9Y666 | |
| GSDSEYEVDSNHQKA | 2056 | Q58EX2 | |
| LINKDETEHTGQESY | 4996 | P21817 | |
| INKDETEHTGQESYV | 4926 | Q92736 | |
| DEEVDINGTHTYTCN | 186 | Q9BZW8 | |
| ASDYAGKQAHVELAE | 891 | P28340 | |
| AEYLFDTHTLGNENK | 226 | Q8N4E7 | |
| AYAGAKTEDHSNSDQ | 786 | Q05469 | |
| EDKQDTDVHYHSLTG | 1771 | Q9HC10 | |
| HNTYVGASEKETELE | 751 | Q12923 | |
| FHSGAQEKNYTIREE | 51 | Q9BZA8 | |
| DASKITQGQFDEHYV | 146 | P17540 | |
| EYRVTQVDGHSSKND | 76 | O43324 | |
| DCHYIDVKGTSQENI | 286 | O14832 | |
| GAKNYFEHEELTVSQ | 221 | Q96CV9 | |
| YHSKTEGAERTNDDS | 881 | Q92834 | |
| DKQETDVHYNSLTGE | 1636 | Q2WGJ9 | |
| YLKEHTLIGSANSQD | 466 | Q9NQT8 | |
| LSISNQYGDDEVTHT | 381 | Q9BST9 | |
| QYGDDEVTHTLQTES | 386 | Q9BST9 | |
| ASSVNYESIKHEPEN | 641 | Q9NQC3 | |
| HSSKEDAYDGVTSEN | 11 | Q9NUM4 | |
| EVTTTNDHGKQYSDG | 1591 | O75445 | |
| EDALVTQYQSKASDH | 916 | Q6WKZ4 | |
| TQYQSKASDHEGLLS | 921 | Q6WKZ4 | |
| HTAGVTEKHSQDSYN | 251 | Q5MJ70 | |
| DLTSVVSGHLDYAKQ | 496 | Q5TGY1 | |
| HIDAALSEENTGKTY | 376 | P03956 | |
| DVSHNAVETGYLNSV | 511 | O95486 | |
| LEQTGHVSSENKYQD | 1381 | Q13576 | |
| DGDSKYSQTSHKLVQ | 621 | Q15788 | |
| YSVVQHADGEKSNVL | 56 | Q92786 | |
| DVDVSSHSYTINGLK | 586 | Q92859 | |
| EEGASYFIDHNQQTT | 66 | Q6IQ23 | |
| DNLQVRGSDYSHSED | 1986 | Q14524 | |
| LSSSSRAGHQEKEQY | 146 | Q8TAV0 | |
| GKQYREELQDSSSFH | 251 | Q9BZV3 | |
| GAHQLDSYSEDAKVS | 101 | Q16651 | |
| AVATGEAHTYESEVK | 3131 | Q4LDE5 | |
| EENIYSVPHDSTQGK | 1101 | Q9NRY4 | |
| GSNALNHTEQYTEAA | 371 | Q8IYS1 | |
| LVSYTNLTQGAKEHE | 86 | Q9UP95 | |
| AGVDSLDDVKNHTYN | 1306 | Q9UK61 | |
| HDLKETNISYSQEAD | 166 | O00116 | |
| INVSNYSLESGHDQK | 451 | Q969H4 | |
| THYAVQDTKGFHTEE | 191 | P98196 | |
| IHSEEEPSEYNKNGN | 111 | P17032 | |
| QVEHDGQQAVSKSYA | 331 | O00241 | |
| DRGDVKNYTHIFESN | 766 | A4UGR9 | |
| TLNETDHSYESHKQQ | 2546 | A4UGR9 | |
| DHSYESHKQQSEIDV | 2551 | A4UGR9 | |
| TDETLEVHDFKNGYT | 96 | Q9H2S6 | |
| KEEFVQGEVQDSHSY | 561 | Q9P2U8 | |
| QGEVQDSHSYKDRVD | 566 | Q9P2U8 | |
| VLNSKHNGEVYDETS | 136 | Q5W0Q7 | |
| ADGSTAYIQHNSKDA | 56 | P52747 | |
| HTSKDSYDQSALQAV | 121 | P52747 | |
| RSNTAEKLYDSNHSG | 106 | Q147U1 | |
| QEGTATLYDSPKDQH | 591 | Q8NB66 | |
| HGASNAYEAKEVVNR | 566 | Q8N427 | |
| DVGVYRSSEHSQDSN | 956 | A0A1B0GUW6 | |
| SDDYQTENKILGVHC | 256 | Q6NXR4 | |
| HDSVYQQNKSVSTDE | 311 | Q6T4P5 | |
| HDSNEFAVGTKNYSV | 491 | A6NJ88 | |
| EEKYTDTLGSIQQHF | 206 | P15498 | |
| DHTDYQTPQGENAKI | 321 | Q9NYB5 | |
| SSQLYEHTVEGGEKQ | 56 | P22105 | |
| DGHYQSASGQKVTLE | 306 | Q8N0Z6 | |
| EVQTKELYSHAQFGD | 896 | Q9Y6L7 | |
| ALENSEEHSAKYSNS | 471 | Q7Z7A4 | |
| EEHSAKYSNSNNSAG | 476 | Q7Z7A4 | |
| SYSVGLNEVEDHIKN | 626 | P55017 | |
| TGDYRSHAVDKIQNT | 136 | O43657 | |
| EHINRGQKTAETDAY | 696 | Q86WI1 | |
| EGVYIHSSCGKTNDQ | 16 | Q8TC07 | |
| VNFEDHSNSGKRTYT | 256 | Q8IYL9 | |
| ETDHNAYTEATKAQR | 801 | Q15393 | |
| VHDTNKGEVSDGYSV | 71 | A0A0K0K1A3 | |
| HQEAVDKEESYESSG | 1121 | P11137 | |
| KELTGSTDQYDQRHA | 116 | P0CJ79 | |
| LTKHYQGNNDTDVFS | 121 | Q96SJ8 | |
| NITHDYNATNGAEIE | 776 | Q96JM2 | |
| IQSHSKVFRNGESYD | 121 | H3BQB6 | |
| EKVTREGSQVYDHDS | 826 | Q502W6 | |
| VIETFHKYASEDSNG | 11 | Q5QJ38 | |
| TTGRENSDQHYSKES | 736 | Q9BXT5 | |
| HTDGNETNVTENYEL | 1396 | Q9BXT5 | |
| VSSDNVADLHEKYSG | 246 | P28074 | |
| DAGHTVYQVSQAEKD | 1591 | A3KMH1 | |
| YSAETINDGQFHTVE | 1236 | O75093 | |
| HGENQYSKSSEFETH | 786 | Q6N021 | |
| TVYDDGEEKNNATVH | 76 | P04004 | |
| IHTGQKTYQGNECEE | 256 | Q14590 | |
| HYALKSNAVQEADSE | 1111 | Q5VZL5 | |
| SKLEHTAQTYSELQG | 456 | O95071 | |
| EVYKHLSSENNTADH | 516 | Q5H9K5 | |
| YKHLQQHESGVEGES | 1071 | Q15911 | |
| IKVDQSHSEDNTYQS | 411 | Q9C099 | |
| DHVEKTFRNYDNITG | 266 | O95970 | |
| DLKKNSSVNEGSTYH | 536 | O14974 | |
| HNLYSSESEDRNAGV | 251 | Q9HAN9 |